Hyperprolactinemia Clinical Trial
Official title:
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension
NCT number | NCT02603549 |
Other study ID # | Pro39357 |
Secondary ID | |
Status | Suspended |
Phase | |
First received | |
Last updated | |
Start date | July 2015 |
Est. completion date | December 2020 |
Verified date | January 2019 |
Source | Cedars-Sinai Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Previous research has identified spontaneous cerebral spinal fluid leakage as a cause for spontaneous intracranial hypotension, leading to positional headache patterns. Typical magnetic resonance imaging findings include subdural fluid collections, enhancement of pachymenginges, engorgement of venous structures, pituitary hyperemia, and sagging of the brain (SEEPS). Because pituitary hyperemia has been documented in cases of spontaneous cerebral spinal fluid leakage and is known to mimic a pituitary tumor or hyperplasia, the investigators would like to like to assess the clinical manifestations and neuroimaging abnormalities of SIH patients with regard to the pituitary gland. Specifically, the investigators are looking to analyze the compression of the pituitary stalk and conduct a systemic evaluation of pituitary function in SIH patients.
Status | Suspended |
Enrollment | 100 |
Est. completion date | December 2020 |
Est. primary completion date | December 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Male or female patients - Age 18 years and older - Diagnosis of SIH: - LP - Brain MRI (SEEPS) Exclusion Criteria: - Pregnant and post-partum females - Nursing mothers - Patients with potential hyperprolactinemia due to: - Hypothyroidism, - Chronic renal disorder - Liver disease (including cirrhosis) - Primary or secondary amenorrhea - Polycystic Ovary Syndrome - Seizure disorder - Illicit drug use |
Country | Name | City | State |
---|---|---|---|
United States | Cedars-Sinai Medical Center | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
Cedars-Sinai Medical Center |
United States,
Mokri B. Cerebrospinal fluid volume depletion and its emerging clinical/imaging syndromes. Neurosurg Focus. 2000 Jul 15;9(1):e6. Review. — View Citation
SCHALTENBRAND G. Normal and pathological physiology of the cerebrospinal fluid circulation. Lancet. 1953 Apr 25;1(6765):805-8. — View Citation
Schievink WI. Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA. 2006 May 17;295(19):2286-96. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparing the levels of prolactin pre and post treatment | 90 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03569787 -
Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
|
||
Completed |
NCT02098668 -
Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
|
N/A | |
Completed |
NCT03038308 -
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT00541554 -
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
|
Phase 4 | |
Completed |
NCT01270711 -
Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
|
N/A | |
Completed |
NCT02956447 -
Administration of Kisspeptin in Patients With Hyperprolactinemia
|
Phase 2 | |
Recruiting |
NCT05033119 -
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
|
||
Completed |
NCT06326840 -
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
|
N/A | |
Withdrawn |
NCT00699530 -
Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
|
N/A | |
Not yet recruiting |
NCT00315081 -
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
|
Phase 3 | |
Recruiting |
NCT04746313 -
Prevalence of Hyperprolactinemia in Systemic Scleroderma
|
||
Terminated |
NCT04146389 -
Hyperprolactinemia and Adrenal Steroidogenesis
|
||
Recruiting |
NCT00914823 -
Kisspeptin Administration in the Adult
|
Phase 1 | |
Completed |
NCT01852331 -
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
|
Phase 2 | |
Completed |
NCT01338298 -
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
|
N/A | |
Completed |
NCT01052948 -
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events
|
N/A | |
Completed |
NCT00436111 -
Characterization of Macroprolactinemia
|
N/A | |
Active, not recruiting |
NCT04439747 -
Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT01742390 -
A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
|
Phase 4 | |
Completed |
NCT00625950 -
Endometriosis Patients Undergoing Quinagolide Treatment
|
Phase 4 |